This report studies the global pharmaceutical robots market
for the forecast period of 2016 to 2021. This market is expected to reach USD
119.5 Million by 2021 from USD 64.4 Million in 2016, at a CAGR of 13.2% during
the forecast period. The key factor driving the growth of the market is the
benefits offered by robotic systems in pharmaceutical manufacturing.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210985096
[141 Pages Report] The overall pharmaceutical robotic
systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46
million by 2021, at a CAGR of 13.2% from 2016 to 2021. Benefits offered by
robotic systems in pharmaceutical manufacturing is a key factor driving the
growth of pharmaceutical robots market.
Robotic systems provide various benefits to pharmaceutical
manufacturing such as lesser space utilization, reduced production downtime, no
labor turnover, enhanced health and safety, better waste management, increased
production flexibility, improved production output and product quality, and
lower operating costs. With the growing pharmaceutical industry and the various
benefits offered by robotic automation, the adoption of robots is likely to
increase in the coming years.
Browse and in-depth TOC on “Pharmaceutical Robots Market”
98 – Tables
40 – Figures
141 – Pages
The global pharmaceutical robots market is segmented on
the basis of type, application, and region.
Based on type, the market is segmented into traditional
robots and collaborative robots. The traditional robots segment is expected to
command the largest share of the global market. The traditional robots segment
is further categorized into articulated, SCARA (selective compliance
articulated robot arm), delta/parallel, Cartesian, and other robots (which
include spherical and dual-arm robots). The articulated robots segment
accounted for the largest share of the global pharmaceutical traditional robots
market in 2016.
On the basis of application, the global pharmaceutical
robots market is segmented into picking and packaging, inspection of pharmaceutical
drugs, and laboratory applications. In 2016, the picking and packaging segment
accounted for the largest share of the global pharmaceutical robots market.
Factors such as demand for personalized packaging configurations and advantages
of robots in pharmaceutical manufacturing such as high speed, accuracy, ability
to track and trace, error-free operation, fewer accidents, and better
utilization of the floor space are contributing to the large share of the
picking and packaging segment.
Regional Growth Analysis:
The pharmaceutical robotic systems market in APAC is
expected to grow at the highest CAGR during the forecast period owing to
factors such as the increase in domestic industrial robots companies,
flourishing pharmaceutical industry, increasing number of conferences and
exhibitions, investments and funding in the industrial robots industry, and
Japan’s Robot Strategy.
Key Players:
Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation
(Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd.
(Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan),
Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa
Electric Corporation (Japan), and Shibuya Corporation (Japan) are the prominent
players in the global pharmaceutical robots market.
The following are the major objectives of the study.
·
To describe and forecast the pharmaceutical
robotic systems market, in terms of value, by type, application, and region
·
To describe and forecast the pharmaceutical
robotic systems market, by region–Asia Pacific (APAC), Europe, North America,
and Rest of the World (RoW) along with their respective countries
·
To provide detailed information regarding major
factors influencing market growth (drivers, restraints, opportunities, and
challenges)
·
To strategically analyze micromarkets with
respect to individual growth trends, prospects, and contributions to the
overall market
·
To study the complete value chain of
pharmaceutical robotic systems
Major Market Developments
·
In 2016, Kawasaki opened a Tokyo Robot Center
Showroom in Odaiba, Tokyo, Japan. The new facility offers robotics-related
information.
·
In 2016, Yaskawa launched the MOTOMAN-MH5BM, a
six-axis vertical articulated robot. The robot is ideal for sterile or hygienic
environments such as the biomedical field, which includes drug discovery
research, pharmaceutical and medical industry, as well as the beverage
industry.
·
In 2016, FANUC collaborated with NVIDIA (U.S.)
to implement Artificial Intelligence on the FANUC Intelligent Edge Link and
Drive (FIELD) system. This is aimed to increase robotics productivity and bring
new capabilities to automated factories across the globe. Moreover, the
advances in artificial intelligence aim to allow robots to watch & learn,
and improve its capabilities.
·
In 2016, Mitsubishi established two new Factory
Automation (“FA”) centers in Italy and South Africa. With this expansion, the
company aimed at expanding the FA product support network in Southern Europe and
Africa, along with strengthening and accelerating local customer service.